ICW Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,600
Closed -$3.51M 147
2025
Q3
$3.51M Buy
+4,600
New +$3.42M 1.26% 24

Other funds holding LLY

ICW Investment Advisors's LLY Position: Q2 2026 in Review

ICW Investment Advisors increased its Eli Lilly (LLY) stake by 0.45% in Q2 2026, buying an estimated $15.3K and bringing the position to 3,354 shares worth $4.02M. The position accounts for 1.41% of the portfolio, ranked #16.

ICW Investment Advisors first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $6.07M in Q4 2025. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • ICW Investment Advisors held 3,354 shares of Eli Lilly worth $4.02M as of Q2 2026.
  • ICW Investment Advisors bought 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
  • Eli Lilly made up 1.41% of ICW Investment Advisors's portfolio in Q2 2026, its #16 holding.
  • ICW Investment Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • ICW Investment Advisors's Eli Lilly position peaked at $6.07M in Q4 2025.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on ICW Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.